ADA Technologies receives grant for cancer research

December 4, 2008: ADA Technologies, Inc. received a $149,121 grant from the National Cancer Institute for research and development of nanotechnology imaging and sensing platforms for improved detection and diagnosis of cancer.

ADA’s research focuses on developing a nano-enabled sensing platform for analysis of biomolecules, such as cancer biomarkers, that is more sensitive than existing technologies. Analysis platforms that provide high sensitivity and high throughput are critical to cancer biomarker detection.

“Our research will provide the scientific and medical communities with a reliable, ready-to-use platform that is capable of detecting multiple biomolecules to facilitate cancer biomarker screening and improve cancer diagnosis,” said Xichun Zhou, ADA principal investigator.

ADA’s R&D efforts related to nanotechnology imaging and sensing platforms began in 2007.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.